Display options
Share it on

Arthritis Care Res (Hoboken). 2021 Oct 04; doi: 10.1002/acr.24801. Epub 2021 Oct 04.

The Prevalence of Fibromyalgia Syndrome in Active Duty Military Personnel.

Arthritis care & research

Katrina M Lawrence-Wolff, Jay B Higgs, Stacey Young-McCaughan, Jim Mintz, Edna B Foa, Patricia A Resick, Kevin M Kelly, Douglas M Maurer, Adam M Borah, Jeffrey S Yarvis, Brett T Litz, Bernard A Hildebrand, Douglas E Williamson, Alan L Peterson,

Affiliations

  1. Brooke Army Medical Center, Joint Base San Antonio-Fort Sam Houston.
  2. University of Texas Health Science Center at San Antonio.
  3. South Texas Veterans Health Care System, San Antonio.
  4. Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  5. Duke Health, Durham.
  6. Carl R. Darnall Army Medical Center, Fort Hood.
  7. VA Boston Healthcare System, Boston.
  8. Boston University School of Medicine, Boston.
  9. University of the Incarnate Word School of Osteopathic Medicine, San Antonio.
  10. Durham VA Healthcare System, Durham.
  11. University of Texas at San Antonio.

PMID: 34606694 DOI: 10.1002/acr.24801

Abstract

OBJECTIVE: Previous research with civilian populations has found strong associations between fibromyalgia (FM) and posttraumatic stress disorder (PTSD). This study is the first large-scale investigation of the prevalence of FM in military service members with and without PTSD.

METHODS: Participants were active duty military recruited into either an epidemiological cohort study of service members prior to a military deployment or 1 of 3 PTSD treatment trials. Instruments used to document FM and PTSD included the PTSD Checklist - Stressor-Specific Version (PCL-S), the PTSD Symptom Scale-Interview (PSS-I), and the 2012 American College of Rheumatology fibromyalgia questionnaire.

RESULTS: Across the 4 studies, 4,376 subjects completed surveys. The prevalence of FM was 2.9% in the predeployment cohort and the prevalence was significantly higher in individuals with PTSD (10.8%) compared to those without PTSD (0.8%). In the treatment trials, all of the participants met criteria for PTSD prior to starting treatment and the prevalence of FM was 39.7%.

CONCLUSION: The prevalence of FM in active duty service members preparing to deploy is similar to that reported for the general population of the U.S., but higher than expected for a predominantly male cohort. Furthermore, the prevalence of FM was significantly higher in service members with comorbid PTSD and highest among those seeking treatment for PTSD. Further investigation is needed to determine the factors linking PTSD and FM.

This article is protected by copyright. All rights reserved.

Publication Types